Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo

Phytotherapy Research

Volumn 28, Issue 4, 2014, Pages 560-567

  Ma, Xiuying ^a   Jin, Shaoju ^a,b   Zhang, Yuanyuan ^a   Wan, Lihong ^a   Zhao, Yanyan ^c   Zhou, Liming ^a  

^a SICHUAN UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

antiproliferative; cell cycle; H22; nobiletin; SMMC 7721

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; DOXORUBICIN; NOBILETIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GRAFT; CANCER INHIBITION; CELL GROWTH ASSAY; CELL PROLIFERATION; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; RUTACEAE; UPREGULATION; WESTERN BLOTTING; ZHISHI;

RUTACEAE;

ANTIPROLIFERATIVE; CELL CYCLE; H22; NOBILETIN; SMMC-7721;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; FLAVONES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84897972757     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5024     Document Type: Article

References (39)

1. Bosland MC, McCormick DL, Melamed J, Walden PD, Zeleniuch-Jacquotte A, Lumey LH,. 2002. Chemoprevention strategies for prostate cancer. Eur J Cancer Prev 11 (Suppl 2): S18-27. PMID: 12570331.
2. Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH,. 2004. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. Mol Pharmacol 65 (1): 77-84. doi: 10.1124/mol.65.1.7765/1/77 [pii]. PMID: 14722239.
3. Choi YH, Lee WH, Park KY, Zhang L,. 2000. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn J Cancer Res 91 (2): 164-173. PMID: 10761703.
4. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN,. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (4): 1183-1188. dio: S0016508594003033 [pii]. PMID: 7926468.
5. Gullett NP, Ruhul Amin AR, Bayraktar S, et al,. 2010. Cancer prevention with natural compounds. Semin Oncol 37 (3): 258-281. doi: S0093-7754(10)00093-X [pii] 10.1053/j.seminoncol.2010.06.014. PMID: 20709209.
6. Hida T, Yatabe Y, Achiwa H, et al,. 1998. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58 (14): 3761-3764. PMID: 9731479.
7. Hikosaka A, Asamoto M, Hokaiwado N, et al,. 2004. Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 25 (3): 381-387. doi: 10.1093/carcin/bgh031bgh031 [pii]. PMID: 14656947.
8. Huang YT, Hwang JJ, Lee PP, et al,. 1999. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 128 (5): 999-1010. doi: 10.1038/sj.bjp.0702879. PMID: 10556937.
9. Hwang D, Scollard D, Byrne J, Levine E,. 1998. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90 (6): 455-460. PMID: 9521170.
10. Kandaswami C, Perkins E, Soloniuk DS, Drzewiecki G, Middleton E, Jr., 1991. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett 56 (2): 147-152. PMID: 1998943.
11. Kang TB, Liang NC,. 1997. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54 (9): 1013-1018. doi: S0006-2952(97)00260-8 [pii]. PMID: 9374422.
12. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M,. 1999. Effect of citrus flavonoids on HL-60 cell differentiation. Anticancer Res 19 (2A): 1261-1269. PMID: 10368686.
13. Kim SW, Kim CE, Kim MH,. 2011. Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells. Biochem Biophys Res Commun 415 (4): 602-607. doi: S0006-291X(11)01949-8 [pii] 10.1016/j.bbrc.2011.10.115. PMID: 22074828.
14. Lu H, Song J, Jia XB, Feng L,. Antihepatoma activity of the acid and neutral components from Ganoderma lucidum. Phytother Res. 26 (9): 1294-300.
15. Manthey JA, Guthrie N,. 2002. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem 50 (21): 5837-5843. doi: jf020121d [pii]. PMID: 12358447.
16. Murakami A, Nakamura Y, Torikai K, et al,. 2000. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 60 (18): 5059-5066. PMID: 11016629.
17. Ohnishi H, Asamoto M, Tujimura K, et al,. 2004. Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci 95 (12): 936-942. PMID: 15596041.
18. Onda K, Horike N, Suzuki TI, Hirano T,. 2013. Polymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytes. Phytother Res 27 (2): 312-316.
19. Oshima M, Dinchuk JE, Kargman SL, et al,. 1996. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (5): 803-809. doi: S0092-8674(00)81988-1 [pii]. PMID: 8945508.
20. Reddy BS, Rao CV, Seibert K,. 1996. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56 (20): 4566-4569. PMID: 8840961.
21. Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M,. 1997. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57 (7): 1276-1280. PMID: 9102213.
22. Rodriguez J, Yáñez J, Vicente V, et al,. 2002. Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity. Melanoma Res 12 (2): 99-107. PMID: 11930105.
23. Sano H, Kawahito Y, Wilder RL, et al,. 1995. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55 (17): 3785-3789. PMID: 7641194.
24. Shao ZM, Wu J, Shen ZZ, Barsky SH,. 1998. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58 (21): 4851-4857. PMID: 9809990.
25. Shen F, Weber G,. 1997. Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncol Res 9 (11-12): 597-602. PMID: 9563007.
26. Singhal RL, Yeh YA, Praja N, Olah E, Sledge GW, Jr., Weber G,. 1995. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 208 (1): 425-431. doi: S0006291X85713551 [pii]. PMID: 7887960.
27. Stavric B,. 1994. Antimutagens and anticarcinogens in foods. Food Chem Toxicol 32 (1): 79-90. PMID: 8132169.
28. Suzuki M, Youle RJ, Tjandra N,. 2000. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103 (4): 645-654. doi: S0092-8674(00)00167-7 [pii]. PMID: 11106734.
29. Tomozawa S, Nagawa H, Tsuno N, et al,. 1999. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 81 (8): 1274-1279. doi: 10.1038/sj.bjc.6694262. PMID: 10604722.
30. Tsujii M, Kawano S, DuBois RN,. 1997. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 94 (7): 3336-3340. PMID: 9096394.
31. Tucker ON, Dannenberg AJ, Yang EK, et al,. 1999. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59 (): 987-990. PMID: 10070951.
32. Vasilevskaya IA, Rakitina TV, O'Dwyer PJ,. 2004. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines. Mol Pharmacol 65 (1): 235-243. doi: 10.1124/mol.65.1.23565/1/235 [pii]. PMID: 14722256.
33. Wattenberg LW,. 1985. Chemoprevention of cancer. Cancer Res 45 (1): 1-8. PMID: 3880665.
34. Wrzesinski SH, Taddei TH, Strazzabosco M,. 2011. Systemic therapy in hepatocellular carcinoma. Clin Liver Dis 15 (2): 423-441, vii-x. doi: S1089-3261(11)00003-1 [pii] 10.1016/j.cld.2011.03.002. PMID: 21689622.
35. Wu JJ, Cui Y, Yang YS, et al,. 2013. Mild mitochondrial depolarization is involved in a neuroprotective mechanism of citrus sunki peel extract. Phytother Res 27 (4): 564-71.
36. Wu YY, Wan LH, Zheng XW, et al,. 2012. Inhibitory effects of β,β-dimethylacrylshikonin on hepatocellular carcinoma in vitro and in vivo. Phytother Res 26 (5): 764-71.
37. Yin XM, Oltvai ZN, Korsmeyer SJ,. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369 (6478): 321-323. doi: 10.1038/369321a0. PMID: 8183370.
38. Zheng SY, Li DC, Zhang ZD, Zhao J, Ge JF,. 2005. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol 11 (22): 3446-3450. PMID: 15948252.
39. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K,. 1999. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59 (1): 198-204. PMID: 9892207.